Stockscreener 앱 받기
16.48
2.69%
-0.455
Uniqure N V 주식(QURE)의 최신 뉴스
Parkman Healthcare Partners LLC Sells 71,167 Shares of uniQure N.V. $QURE - MarketBeat
Huntington’s Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Spark therapeutics, Chong Kun Dang Pharma, Neuvivo, UniQure Biopharma - Barchart.com
OMERS ADMINISTRATION Corp Takes $152,000 Position in uniQure N.V. $QURE - MarketBeat
Cubist Systematic Strategies LLC Makes New $2.56 Million Investment in uniQure N.V. $QURE - MarketBeat
uniQure (NASDAQ:QURE) Receives "Buy" Rating from Chardan Capital - MarketBeat
uniQure stock maintains Buy rating at H.C. Wainwright on promising Fabry data - Investing.com Nigeria
683 Capital Management LLC Boosts Stock Holdings in uniQure N.V. $QURE - MarketBeat
What does recent volatility data suggest for uniQure N.V.Market Growth Report & Real-Time Volume Analysis - Newser
Nantahala Capital Management LLC Has $29.21 Million Stock Holdings in uniQure N.V. $QURE - MarketBeat
uniQure reports positive initial data for Fabry disease gene therapy By Investing.com - Investing.com Nigeria
UniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data (NASDAQ:QURE) - Seeking Alpha
Chart based analysis of uniQure N.V. trendsCEO Change & Daily Entry Point Alerts - Newser
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing - GlobeNewswire
uniQure (QURE) Rating Reaffirmed with $70 Price Target by HC Wai - GuruFocus
uniQure's Investigational Gene Therapy Shows Promising Efficacy With Manageable Safety Risks For Fabry Disease - Benzinga
UniQure Says Early Data for Fabry Disease Gene Therapy Shows Promise - MarketScreener
Long term hold vs stop loss in uniQure N.V.Weekly Trade Report & High Yield Equity Trading Tips - Newser
uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease - The Manila Times
uniQure reports positive initial data for Fabry disease gene therapy - Investing.com
Is uniQure N.V. stock a top performer YTDJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - 더경남뉴스
Is uniQure N.V. exposed to political riskPortfolio Risk Summary & Smart Allocation Stock Reports - 더경남뉴스
uniQure N.V. stock chart pattern explainedJuly 2025 WrapUp & Community Trade Idea Sharing Platform - Newser
Using RSI to spot recovery in uniQure N.V.Index Update & Community Shared Stock Ideas - Newser
Rare Disease Therapy Approvals By FDA Speed Up Via New ProcessNeurogene (NASDAQ:NGNE) - Benzinga
Is uniQure N.V. stock overvalued or fairly pricedJuly 2025 Snapshot & Capital Efficient Trade Techniques - خودرو بانک
What indicators show strength in uniQure N.V.2025 Market Outlook & Free Risk Controlled Daily Trade Plans - Newser
Understanding uniQure N.V.’s price movementWeekly Earnings Recap & Low Drawdown Trading Techniques - Newser
What’s the RSI of uniQure N.V. stockJuly 2025 Movers & Low Risk Growth Stock Ideas - خودرو بانک
Visual analytics tools that track uniQure N.V. performanceQuarterly Portfolio Review & Weekly High Potential Alerts - Newser
Price action breakdown for uniQure N.V.2025 Valuation Update & High Conviction Buy Zone Alerts - Newser
What technical models suggest about uniQure N.V.’s comebackJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - Newser
Is now a turning point for uniQure N.V.Wall Street Watch & Weekly Top Stock Performers List - Newser
Has uniQure N.V. formed a bullish divergenceJuly 2025 Levels & Precise Buy Zone Identification - Newser
Will a bounce in uniQure N.V. offer an exitMarket Activity Summary & Daily Momentum Trading Reports - Newser
Relative strength of uniQure N.V. in sector analysisJuly 2025 Analyst Calls & Daily Technical Stock Forecast Reports - Newser
Ranking uniQure N.V. among high performing stocks via tools2025 Key Lessons & Consistent Growth Equity Picks - Newser
Can uniQure N.V. rally from current levelsJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser
Using economic indicators to assess uniQure N.V. potential2025 Historical Comparison & Smart Investment Allocation Tips - Newser
Should I hold or sell uniQure N.V. nowJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - خودرو بانک
Can uniQure N.V. outperform in the next rallyJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Using data tools to time your uniQure N.V. exitPortfolio Profit Report & Weekly Stock Performance Updates - Newser
0.93%
0.10%
자본화:
|
볼륨(24시간):